To contentTo navigationTo search
Logotype

News & Events

Press Releases


2024

Implantica announces new health-economics data publication showing RefluxStop™’s superior cost-effectiveness for the Swiss healthcare system

11.07.2024
 | Other press releases
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, reports the study, “Analysis of Cost-Effectiveness in Switzerland for a New Implantable Device to Treat Chronic Gastroesophageal Reflux Disease,” was published recently by the Journal of Medical Economics (https://pubmed.ncbi.nlm.nih.gov/38820006/#:~:text=Gastroesophageal%20reflux%20disease%20(GERD)%20is,MSA%5D)%20in%20selected%20cases)1.

Implantica announces further expansion of RefluxStop™ access in the UK NHS public Hospital Network

19.06.2024
 | Other press releases
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces that another NHS Trust hospital, the University Hospital Southampton, a leading public teaching hospital in the south of England, is now performing the RefluxStop™ procedure.

Bulletin from the Annual General Meeting of Implantica AG

22.05.2024
 | Regulatory
Today, May 22, 2024, the annual general meeting (the “AGM”) of Implantica AG (publ) was held in Ruggel, Liechtenstein. The general meeting resolved to adopt all of the board of directors’ resolution proposals. A summary of the resolutions adopted at the general meeting is set out below.

Implantica publishes Interim Report January – March 2024 (Q1)

15.05.2024
 | Regulatory
RefluxStop™ on path to become standard of care for acid reflux treatment

Implantica announces the eighth RefluxStop™ center of excellence in Italy

14.05.2024
 | Other press releases
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, welcomes a new hospital performing the RefluxStop™ procedure in Italy, Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone.

Implantica presents the first quarter 2024 on May 15 at 15:00 CEST

08.05.2024
 | Other press releases
Implantica AG (publ) invites investors to a presentation of the first quarter 2024 at 15:00 CEST on May 15. The interim report for the first quarter will be published at 8:00 a.m. CEST on the same day.

Implantica’s RefluxStop™ is now available in seven hospitals in Spain adding two new centers of excellence

02.05.2024
 | Other press releases
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces that Dra. Beatriz Guil of Universitario de Canarias in the Canary Islands and Dr. Carlos Milliani of Universitario de Fuenlabrada in the Madrid Region are offering their patients the RefluxStop™ procedure.

Notice of Annual General Meeting of Implantica AG

01.05.2024
 | Regulatory
The depository receipt holders of Implantica AG, reg. no. FL-0002.629.889-3, are hereby invited to attend the annual general meeting to be held on Wednesday, May 22, 2024, at 14:30 at Hotel Kommod, Industriering 14, 9491 Ruggell, Liechtenstein.

Implantica Announces Real-World Clinical Data from over 200 Patients treated across five RefluxStop™ Centers in Europe Presented at SAGES in Cleveland

30.04.2024
 | Other press releases
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, reports many presentations including new RefluxStop™ real-world data from over 200 patients at five hospitals across Europe, were presented in Scientific Sessions at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Annual Scientific Meeting

Implantica publishes Annual Report 2023

26.04.2024
 | Regulatory
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company’s website.
Load more